|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
IE66205B1
(en)
|
1990-06-14 |
1995-12-13 |
Paul A Bartlett |
Polypeptide analogs
|
|
US5650489A
(en)
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
|
US5384253A
(en)
|
1990-12-28 |
1995-01-24 |
Dekalb Genetics Corporation |
Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
|
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
|
ATE194977T1
(de)
|
1991-09-06 |
2000-08-15 |
Yoshitomi Pharmaceutical |
4-amino(alkyl)cyclohexan-1-carboxamidverbindung n und ihre verwendung
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
US5702932A
(en)
|
1992-07-20 |
1997-12-30 |
University Of Florida |
Microinjection methods to transform arthropods with exogenous DNA
|
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
|
EP0710283A4
(en)
|
1993-07-22 |
1997-07-02 |
Merck & Co Inc |
THE EXPRESSION OF HUMAN INTERLEUKIN-1-g (b) IN A TRANSGENIC ANIMAL
|
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
|
US5593853A
(en)
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
|
US5539083A
(en)
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
|
US5656610A
(en)
|
1994-06-21 |
1997-08-12 |
University Of Southern California |
Producing a protein in a mammal by injection of a DNA-sequence into the tongue
|
|
US5525735A
(en)
|
1994-06-22 |
1996-06-11 |
Affymax Technologies Nv |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
|
US5549974A
(en)
|
1994-06-23 |
1996-08-27 |
Affymax Technologies Nv |
Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
|
|
US5736524A
(en)
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
|
US5843780A
(en)
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
|
DE69638269D1
(de)
|
1995-06-14 |
2010-11-18 |
Univ California |
Hochaffine humane antikörper gegen tumorantigene
|
|
US5569588A
(en)
|
1995-08-09 |
1996-10-29 |
The Regents Of The University Of California |
Methods for drug screening
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US5780448A
(en)
|
1995-11-07 |
1998-07-14 |
Ottawa Civic Hospital Loeb Research |
DNA-based vaccination of fish
|
|
GB9807935D0
(en)
|
1998-04-14 |
1998-06-10 |
Univ Edinburgh |
Lineage specific cells and progenitor cells
|
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
|
NZ334613A
(en)
|
1996-08-12 |
2002-02-01 |
Welfide Corp |
Pharmaceutical agents comprising Rho kinase inhibitor
|
|
US5981274A
(en)
|
1996-09-18 |
1999-11-09 |
Tyrrell; D. Lorne J. |
Recombinant hepatitis virus vectors
|
|
EP0981352B8
(en)
|
1997-05-07 |
2009-06-17 |
Pharma Mar, S.A. |
Use of aplidine for the treatment of cardiovascular diseases
|
|
JP3626206B2
(ja)
|
1997-06-13 |
2005-03-02 |
ルードヴィッヒ インスティテュート フォー キャンサー リサーチ |
Ｓｍａｄ６及びその使用
|
|
AU757046B2
(en)
|
1997-07-01 |
2003-01-30 |
Warner-Lambert Company |
4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
|
|
US5994624A
(en)
|
1997-10-20 |
1999-11-30 |
Cotton Incorporated |
In planta method for the production of transgenic plants
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
US20060263382A1
(en)
|
1998-06-20 |
2006-11-23 |
Richard Hotchkiss |
Membrane-permeant peptide complexes for treatment of sepsis
|
|
WO2000005344A1
(en)
|
1998-07-24 |
2000-02-03 |
The Carnegie Institution Of Washington |
METHOD FOR MAINTENANCE AND PROPAGATION OF GERMLINE STEM CELLS USING MEMBERS OF THE TGF-β FAMILY OF GROWTH FACTORS
|
|
GB9819912D0
(en)
|
1998-09-11 |
1998-11-04 |
Univ Edinburgh |
Propagation and/or derivation of embryonic stem cells
|
|
DE69924641D1
(de)
|
1999-01-07 |
2005-05-12 |
Warner Lambert Company Llc Mor |
Behandlung von asthma anhand von mek-inhibitoren
|
|
US6703420B1
(en)
|
1999-03-19 |
2004-03-09 |
Bristol-Myers Squibb Pharma Company |
Amino-thio-acrylonitriles as MEK inhibitors
|
|
AU5250400A
(en)
|
1999-06-18 |
2001-01-09 |
Mitsubishi Pharma Corporation |
Osteogenesis promoters
|
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
|
WO2001017562A1
(fr)
|
1999-09-02 |
2001-03-15 |
Yamanouchi Pharmaceutical Co., Ltd. |
Agents promoteurs de l'osteogenese
|
|
US20020142457A1
(en)
|
1999-12-28 |
2002-10-03 |
Akihiro Umezawa |
Cell having the potentiality of differentiation into cardiomyocytes
|
|
US6692736B2
(en)
|
2000-03-24 |
2004-02-17 |
Cell Genesys, Inc. |
Cell-specific adenovirus vectors comprising an internal ribosome entry site
|
|
WO2002006213A2
(en)
|
2000-07-19 |
2002-01-24 |
Warner-Lambert Company |
Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
|
|
TWI336328B
(en)
|
2001-03-23 |
2011-01-21 |
Bayer Healthcare Llc |
Rho-kinase inhibitors
|
|
JP4329003B2
(ja)
|
2001-03-23 |
2009-09-09 |
バイエル コーポレイション |
Ｒｈｏキナーゼ阻害剤
|
|
WO2002088346A2
(en)
|
2001-05-01 |
2002-11-07 |
National Research Council Of Canada |
A system for inducible expression in eukaryotic cells
|
|
WO2003027277A1
(en)
|
2001-09-21 |
2003-04-03 |
Japan Science And Technology Corporation |
Method of screening reporgramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs
|
|
EP1456380B1
(en)
|
2001-11-02 |
2012-04-18 |
Giuliani International Limited |
Smad7 inhibitors for the treatment of cns diseases
|
|
JP4505228B2
(ja)
|
2002-01-10 |
2010-07-21 |
バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト |
Ｒｈｏ−キナーゼ阻害剤
|
|
US6924290B2
(en)
|
2002-01-23 |
2005-08-02 |
Bayer Pharmaceuticals Corporation |
Rho-kinase inhibitors
|
|
MXPA04007196A
(es)
|
2002-01-23 |
2005-06-08 |
Bayer Pharmaceuticals Corp |
Inhibidores de rho-quinasa.
|
|
ATE306810T1
(de)
|
2002-03-05 |
2005-11-15 |
Artemis Pharmaceuticals Gmbh |
Durch inzucht erzeugte von embryonalen stammzellen abgeleitete mäuse
|
|
TWI343377B
(en)
|
2002-03-13 |
2011-06-11 |
Array Biopharma Inc |
N3 alkylated benzimidazole derivatives as mek inhibitors
|
|
AU2003220935A1
(en)
|
2002-04-03 |
2003-10-13 |
Sumitomo Pharmaceuticals Company, Limited. |
Benzamide derivatives
|
|
GB0210539D0
(en)
|
2002-05-08 |
2002-06-19 |
Univ Edinburgh |
Control of es cell self renewal and lineage specification, and medium therefor
|
|
US7737153B2
(en)
|
2002-10-28 |
2010-06-15 |
Bayer Schering Pharma Aktiengesellschaft |
Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
|
|
MXPA05003431A
(es)
|
2002-11-15 |
2005-07-05 |
Warner Lambert Co |
Quimioterapia de combinacion.
|
|
EP1572984B8
(en)
|
2002-12-16 |
2016-06-01 |
Technion Research & Development Foundation Ltd. |
Feeder-free, xeno-free culture system for human embryonic stem cells
|
|
AU2004212490B2
(en)
|
2003-02-10 |
2008-05-15 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
AU2003901099A0
(en)
|
2003-03-11 |
2003-03-27 |
Es Cell International Pte Ltd. |
Methods of inducing differentiation of stem cells
|
|
US20050075276A1
(en)
|
2003-03-14 |
2005-04-07 |
Christopher Rudd |
Use of inhibitors of glycogen synthase-3 to augment CD28 dependent -T-cell responses
|
|
US20070010008A1
(en)
|
2005-06-29 |
2007-01-11 |
Tissuetech, Inc. |
Ex vivo expansion of primary animal cells
|
|
CA2529752A1
(en)
|
2003-06-20 |
2005-09-15 |
The Regents Of The University Of California |
Polypeptide transduction and fusogenic peptides
|
|
WO2005033298A1
(ja)
|
2003-10-03 |
2005-04-14 |
Keiichi Fukuda |
幹細胞から心筋細胞を分化誘導する方法
|
|
EP2468729B1
(en)
|
2003-10-15 |
2013-12-25 |
Ube Industries, Ltd. |
Novel indazole derivative
|
|
WO2005038010A2
(en)
|
2003-10-16 |
2005-04-28 |
The University Court Of The University Of Edinburgh |
Control of es cell self-renewal and lineage specification, and medium therefor
|
|
US20070141703A1
(en)
|
2003-11-19 |
2007-06-21 |
Stanley Edouard G |
Methods for producing blood products from pluripotent cells in cell culture
|
|
NZ547481A
(en)
|
2003-11-19 |
2009-12-24 |
Array Biopharma Inc |
Heterocyclic inhibitors of mek and methods of use thereof
|
|
US20070269412A1
(en)
|
2003-12-02 |
2007-11-22 |
Celavie Biosciences, Llc |
Pluripotent cells
|
|
EP1713775A4
(en)
|
2004-01-30 |
2009-08-12 |
Smithkline Beecham Corp |
CHEMICAL COMPOUNDS
|
|
EP1740601B1
(en)
|
2004-04-21 |
2012-12-05 |
The University of Chicago |
Myosin light chain kinase inhibitors and their use
|
|
JP5102030B2
(ja)
|
2004-08-13 |
2012-12-19 |
ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド |
ヒト胚性幹細胞における自己再生および分化のための組成物および方法
|
|
US20080268533A1
(en)
|
2004-08-25 |
2008-10-30 |
University Of Georgia Research Foundation, Inc. |
Methods and Compositions Utilizing Myc and Gsk3Beta to Manipulate the Pluripotency of Embryonic Stem Cells
|
|
US20060182724A1
(en)
|
2005-02-15 |
2006-08-17 |
Riordan Neil H |
Method for expansion of stem cells
|
|
CN102898364A
(zh)
|
2005-05-18 |
2013-01-30 |
阵列生物制药公司 |
Mek的杂环抑制剂及其使用方法
|
|
US7601699B2
(en)
|
2005-08-01 |
2009-10-13 |
Nupotential, Inc. |
Production of reprogrammed cells with restored potential
|
|
CA2621161A1
(en)
|
2005-09-08 |
2007-03-15 |
The Government Of The United States Of America As Represented By The Sec Retary Of The Department Of Health And Human Services |
Methods for promoting stem cell proliferation and survival
|
|
US8217042B2
(en)
|
2005-11-11 |
2012-07-10 |
Zentaris Gmbh |
Pyridopyrazines and their use as modulators of kinases
|
|
US20090227032A1
(en)
|
2005-12-13 |
2009-09-10 |
Kyoto University |
Nuclear reprogramming factor and induced pluripotent stem cells
|
|
CN101864392B
(zh)
|
2005-12-13 |
2016-03-23 |
国立大学法人京都大学 |
核重新编程因子
|
|
GB0601538D0
(en)
|
2006-01-26 |
2006-03-08 |
Univ Birmingham |
Epigenetic analysis
|
|
US20090186076A1
(en)
|
2006-02-01 |
2009-07-23 |
Kazunori Kataoka |
Combined Use of TGF-Beta Signaling Inhibitor and Antitumor Agent
|
|
US7541186B2
(en)
|
2006-02-22 |
2009-06-02 |
University Of Washington |
Method of generating human retinal progenitors from embryonic stem cells
|
|
GB0615327D0
(en)
|
2006-03-30 |
2006-09-13 |
Univ Edinburgh |
Culture medium containing kinase inhibitors and uses thereof
|
|
EP1999249B8
(en)
|
2006-03-30 |
2012-02-15 |
The University Court Of The University of Edinburgh |
Culture medium containing kinase inhibitors. and uses thereof
|
|
US8741643B2
(en)
|
2006-04-28 |
2014-06-03 |
Lifescan, Inc. |
Differentiation of pluripotent stem cells to definitive endoderm lineage
|
|
WO2007130474A2
(en)
|
2006-05-02 |
2007-11-15 |
Wisconsin Alumni Research Foundation |
Method of differentiating stem cells into cells of the endoderm and pancreatic lineage
|
|
US20070298496A1
(en)
|
2006-06-23 |
2007-12-27 |
Hung-Chih Kuo |
Method of deriving pluripotent stem cells from a single blastomere
|
|
CA2656398A1
(en)
|
2006-06-30 |
2008-01-10 |
Schering Corporation |
Substituted piperidines that increase p53 activity and the uses thereof
|
|
EP2044056B1
(en)
|
2006-07-14 |
2012-08-22 |
Novartis AG |
Pyrimidine derivatives as alk-5 inhibitors
|
|
US20080020014A1
(en)
|
2006-07-19 |
2008-01-24 |
Paul Consigny |
Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders
|
|
CN101563449A
(zh)
|
2006-09-22 |
2009-10-21 |
理化学研究所 |
干细胞培养基及干细胞培养方法
|
|
JP2008099662A
(ja)
|
2006-09-22 |
2008-05-01 |
Institute Of Physical & Chemical Research |
幹細胞の培養方法
|
|
GB0622395D0
(en)
|
2006-11-09 |
2006-12-20 |
Univ Cambridge Tech |
Methods relating to pluripotent cells
|
|
CA2675445C
(en)
|
2007-01-17 |
2014-11-04 |
Wisconsin Alumni Research Foundation |
Improved culture of stem cells
|
|
WO2008088882A2
(en)
|
2007-01-19 |
2008-07-24 |
The J. David Gladstone Institutes |
Methods of generating cardiomyocytes
|
|
WO2008094597A2
(en)
|
2007-01-30 |
2008-08-07 |
University Of Georgia Research Foundation, Inc. |
Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (mmc)
|
|
WO2008105630A1
(en)
|
2007-02-27 |
2008-09-04 |
Procell Therapeutics Inc. |
Combined use of cell permeable nanog and oct4 for increasing self-renewal and suppressing differentiation of stem cells
|
|
ES2703592T3
(es)
|
2007-03-07 |
2019-03-11 |
Mei Pharma Inc |
Combinación de agente anticancerígeno de bencimidazol y un segundo agente anticancerígeno
|
|
WO2008126932A2
(en)
|
2007-04-09 |
2008-10-23 |
Riken |
Epigenetical regulation of brain plasticity
|
|
US8956866B2
(en)
|
2007-04-18 |
2015-02-17 |
Hadasit Medical Research Services And Development Ltd. |
Retinal pigment epithelial cells differentiated from embryonic stem cells with nicotinamide and activin A
|
|
US7878210B2
(en)
|
2007-06-04 |
2011-02-01 |
Philip Morris Usa Inc. |
Cellulose acetate fiber modification
|
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
|
US9213999B2
(en)
*
|
2007-06-15 |
2015-12-15 |
Kyoto University |
Providing iPSCs to a customer
|
|
JP2008307007A
(ja)
|
2007-06-15 |
2008-12-25 |
Bayer Schering Pharma Ag |
出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
|
|
DK2173863T3
(en)
|
2007-06-29 |
2019-01-21 |
Fujifilm Cellular Dynamics Inc |
Automated method and apparatus for embryonic stem cell culture
|
|
US20120282229A1
(en)
|
2007-08-01 |
2012-11-08 |
Christian Kannemeier |
Non-viral delivery of transcription factors that reprogram human somatic cells into a stem cell-like state
|
|
EP2198011B1
(en)
|
2007-08-31 |
2016-06-08 |
Whitehead Institute for Biomedical Research |
Wnt pathway stimulation in reprogramming somatic cells
|
|
AU2008297024B2
(en)
|
2007-10-31 |
2014-08-28 |
Kyoto University |
Nuclear reprogramming method
|
|
US20110151447A1
(en)
|
2007-11-06 |
2011-06-23 |
Children's Medical Center Corporation |
Method to produce induced pluripotent stem (ips) cells from non-embryonic human cells
|
|
JP4604076B2
(ja)
|
2007-11-07 |
2010-12-22 |
国立大学法人静岡大学 |
燃料電池用電解質膜
|
|
WO2009073523A2
(en)
|
2007-11-29 |
2009-06-11 |
Children's Hospital Of Orange County |
De-differentiation of human cells
|
|
EP2224940A1
(en)
|
2007-11-30 |
2010-09-08 |
Cytomatrix PTY LTD |
Methods of inducing pluripotency involving oct4 protein
|
|
WO2009067756A1
(en)
|
2007-11-30 |
2009-06-04 |
Cytomatrix Pty Ltd |
Methods of inducing pluripotency involving sox2 protein
|
|
JP2011516042A
(ja)
|
2008-03-17 |
2011-05-26 |
へルムホルツ・ツェントルム・ミュンヘン−ドイチェス・フォルシュングスツェントルム・ヒューア・ゲズントハイト・ウント・ウムヴェルト（ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング） |
部位特異的組み換えを用いて無ベクター誘導多能性幹（ｉＰＳ）細胞を作製するベクターおよびその方法
|
|
JP5951254B2
(ja)
|
2008-03-17 |
2016-07-13 |
ザ スクリプス リサーチ インスティテュート |
人工多能性幹細胞を作製するための化学的手法と遺伝的手法の組み合わせ法
|
|
CN101550406B
(zh)
*
|
2008-04-03 |
2016-02-10 |
北京大学 |
制备多潜能干细胞的方法,试剂盒及用途
|
|
EP2276838A4
(en)
*
|
2008-04-07 |
2012-02-01 |
Nupotential Inc |
RE-PROGRAMMING A CELL BY INDUCING A PLURIPOTENTIC GENE THROUGH RNA INTERFERENCE
|
|
EP2128245A1
(en)
*
|
2008-05-27 |
2009-12-02 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Generation of induced pluripotent stem (iPS) cells
|
|
CN101848994A
(zh)
|
2008-07-30 |
2010-09-29 |
国立大学法人京都大学 |
有效建立诱导的多能干细胞的方法
|
|
JP2012500005A
(ja)
|
2008-08-12 |
2012-01-05 |
セルラー ダイナミクス インターナショナル， インコーポレイテッド |
ｉＰＳ細胞を生成するための方法
|
|
US8298825B1
(en)
|
2008-08-25 |
2012-10-30 |
The General Hospital Corporation |
TGF-beta receptor inhibitors to enhance direct reprogramming
|
|
EP2356213B1
(en)
|
2008-11-04 |
2019-05-29 |
Viacyte, Inc. |
Stem cell aggregate suspension compositions and methods for differentiation thereof
|
|
ES2489040T3
(es)
|
2008-12-03 |
2014-09-01 |
The Scripps Research Institute |
Cultivos de células madre
|
|
US20100150889A1
(en)
|
2008-12-17 |
2010-06-17 |
The Uab Research Foundation |
Polycistronic Vector For Human Induced Pluripotent Stem Cell Production
|
|
JP6093110B2
(ja)
|
2008-12-17 |
2017-03-08 |
ザ スクリプス リサーチ インスティテュート |
幹細胞の作製と維持
|
|
US20120122212A1
(en)
|
2009-03-06 |
2012-05-17 |
Marica Grskovic |
Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
|
|
EP2414510A4
(en)
|
2009-04-03 |
2013-04-17 |
Mclean Hospital Corp |
INDUCED PLURIPOTENTIAL STEM CELLS
|
|
KR20120017019A
(ko)
|
2009-04-13 |
2012-02-27 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
줄기 세포 배양 방법 및 조성물
|
|
CN102812122A
(zh)
|
2009-05-27 |
2012-12-05 |
索尔克生物学研究院 |
基因矫正的无疾病的诱导的多能干细胞的产生
|
|
US8524498B2
(en)
|
2009-05-29 |
2013-09-03 |
The General Hospital Corporation |
Methods and compositions for homologous recombination in human cells
|
|
WO2010137348A1
(en)
|
2009-05-29 |
2010-12-02 |
Keio University |
Method for selecting clone of induced pluripotent stem cells
|
|
WO2011016588A1
(en)
|
2009-08-07 |
2011-02-10 |
Kyoto University |
Method of efficiently establishing induced pluripotent stem cells
|
|
US9005968B2
(en)
|
2009-10-16 |
2015-04-14 |
The Scripps Research Institute |
Induction of pluripotent cells
|
|
DK2494039T3
(da)
|
2009-10-31 |
2019-08-19 |
Genesis Tech Limited |
Fremgangsmåder til reprogrammering af celler og anvendelser deraf
|
|
JP5898086B2
(ja)
|
2009-11-04 |
2016-04-06 |
セルラー ダイナミクス インターナショナル， インコーポレイテッド |
化学物質を用いるエピソームリプログラミング
|
|
US9018010B2
(en)
|
2009-11-12 |
2015-04-28 |
Technion Research & Development Foundation Limited |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
|
EP2501802A4
(en)
*
|
2009-11-17 |
2013-08-21 |
Advanced Cell Tech Inc |
METHOD FOR PRODUCING HUMAN RPE CELLS AND PHARMACEUTICAL PREPARATIONS FROM HUMAN RPE CELLS
|
|
EP2526189B1
(en)
|
2010-01-22 |
2016-10-12 |
Kyoto University |
Method for improving induced pluripotent stem cell generation efficiency
|
|
AU2011218041B2
(en)
*
|
2010-02-17 |
2015-12-17 |
Lineage Cell Therapeutics, Inc. |
Methods for telomere length and genomic DNA quality control analysis in pluripotent stem cells
|
|
EP2542669B1
(en)
|
2010-03-05 |
2015-01-21 |
Texas Heart Institute |
Ets2 and mesp1 generate cardiac progenitors from fibroblasts
|
|
EP2553086B1
(en)
|
2010-03-31 |
2017-04-19 |
The Scripps Research Institute |
Reprogramming cells
|
|
WO2011159684A2
(en)
|
2010-06-15 |
2011-12-22 |
Cellular Dynamics International, Inc. |
Generation of induced pluripotent stem cells from small volumes of peripheral blood
|
|
US20110306516A1
(en)
|
2010-06-15 |
2011-12-15 |
The New York Stem Cell Foundation |
Methods for producing induced pluripotent stem cells
|
|
JPWO2011158852A1
(ja)
|
2010-06-15 |
2013-08-19 |
国立大学法人 東京大学 |
誘導型多能性幹細胞の製造方法
|
|
US8765470B2
(en)
|
2010-08-04 |
2014-07-01 |
Cellular Dynamics International, Inc. |
Reprogramming immortalized B-cells to induced pluripotent stem cells
|
|
AU2011349446C1
(en)
|
2010-12-22 |
2016-01-21 |
Fate Therapauetics, Inc. |
Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
|
|
WO2013070852A2
(en)
|
2011-11-08 |
2013-05-16 |
Emory University |
Compounds and compositions used to epigenetically transform cells and methods related thereto
|
|
EP2788476B1
(en)
|
2011-12-08 |
2019-05-22 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
|
|
WO2013159103A1
(en)
|
2012-04-20 |
2013-10-24 |
Whitehead Institute For Biomedical Research |
Programming and reprogramming of cells
|
|
EP2853590B1
(en)
|
2012-05-22 |
2018-11-07 |
The University of Tokyo |
Method for producing antigen-specific t cells
|
|
US9166832B1
(en)
|
2013-10-04 |
2015-10-20 |
Altera Corporation |
Methods and apparatus for decision feedback equalization adaptation
|
|
SG11201606934SA
(en)
|
2014-03-04 |
2016-09-29 |
Fate Therapeutics Inc |
Improved reprogramming methods and cell culture platforms
|
|
CA3001917A1
(en)
|
2015-10-16 |
2017-04-20 |
Fate Therapeutics, Inc. |
Platform for the induction & maintenance of ground state pluripotency
|
|
CN108368520B
(zh)
*
|
2015-11-04 |
2023-01-17 |
菲特治疗公司 |
多能细胞的基因组工程改造
|